Scott Morenstein

Director/Board Member at

Primmune Therapeutics, Inc.

50 year

83 connections

Finance

Health Technology

Commercial Services

Profile

Scott D.
Morenstein was the founder of Seaview Securities LLC, founded in 2010, holding the title of Member.
Current jobs include Managing Director at Blackstone Multi-Asset Advisors LLC since 2022, Director at Palvella Therapeutics, Inc., Director at Primmune Therapeutics, Inc., Director at Antios Therapeutics, Inc., Director at Molecular Templates OpCo, Inc., and Director at Avenge Bio, Inc. Former jobs include Director at Synta Pharmaceuticals Corp.
from 2015 to 2016, Independent Director at Celator Pharmaceuticals, Inc. from 2013 to 2016, Director at Gemin X Pharmaceuticals US, Inc., Managing Director at Caxton Advantage Venture Partners, Managing Director at Caxton Alternative Management LP from 2013 to 2022, Managing Director at Valence Life Sciences LLC from 2012 to 2013, Director at Velicept Therapeutics, Inc., Independent Director at Molecular Templates, Inc. from 2017 to 2023, and Principal at Lehman Brothers, Inc. in 2002.
Education includes an undergraduate degree from the University of Pennsylvania, conferred in 1998, and an MBA from Harvard Business School.

Scott Morenstein active positions

Companies	Position	Start
Primmune Therapeutics, Inc. Primmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops orally administered toll-like receptor for cancer immunotherapy	Director/Board Member	-
Molecular Templates OpCo, Inc. Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Functions as an investment holding company	Director/Board Member	-
Antios Therapeutics, Inc. Antios Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company focused on development of innovative therapies to treat and cure viral diseases	Director/Board Member	-
Palvella Therapeutics, Inc. Palvella Therapeutics, Inc. BiotechnologyHealth Technology Engages in developing new therapeutic agents for diseases suffered by patients that lack any treatment choices	Director/Board Member	-
Avenge Bio, Inc. Avenge Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as an immuno-oncology company	Director/Board Member	-
Blackstone Multi-Asset Advisors LLC Blackstone Multi-Asset Advisors LLC Investment ManagersFinance Blackstone Multi-Asset Advisors invests in companies located in the United States. The firm focuses on companies operating across a broad range of sectors and industries. It provides financing for buyout transactions.	Private Equity Investor	01/02/2022

All active positions of Scott Morenstein

Former positions of Scott Morenstein

Companies	Position	End
MOLECULAR TEMPLATES, INC.	Director/Board Member	01/03/2023
Caxton Alternative Management LP Caxton Alternative Management LP Investment ManagersFinance CAM Capital seeks to achieve long-term compounded growth of their portfolio using a fundamentally-driven, opportunistic investment strategy. The firm invests in both public and private markets, across the capital structure. CAM Capital’s investments include public and private equity, corporate credit, real estate, and global macro instruments. Their geographic focus is primarily in the Americas and Western Europe.	Chief Executive Officer	01/02/2022
Synta Pharmaceuticals Corp. Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel pharmaceutical products	Director/Board Member	22/07/2016
░░░░░░░ ░░░░░░░░░░░░░░░ ░░░	░░░░░░░░░░░░░░ ░░░░░░	░░░░░░░░░░
░░░░░░░ ░░░░ ░░░░░░░░ ░░░	░░░░░░░ ░░░░░░ ░░░░░░░░	░░░░░░░░░░

See the detail of Scott Morenstein's experience

Training of Scott Morenstein

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Scott Morenstein's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	18
Synta Pharmaceuticals Corp. Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel pharmaceutical products	Health Technology
Seaview Securities LLC Seaview Securities LLC Investment Banks/BrokersFinance Provides investment banking services focused on the life sciences industry	Finance
Celator Pharmaceuticals, Inc. Celator Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat acute myeloid leukemia and AML with myelodysplasia in children & adults	Health Technology
University of Pennsylvania University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Gemin X Pharmaceuticals US, Inc. Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Develops cancer therapeutic products	Health Technology
Caxton Advantage Venture Partners Caxton Advantage Venture Partners Investment ManagersFinance Caxton Advantage Venture Partners invests primarily in companies in the pharmaceutical and biotechnology sectors	Finance
Lehman Brothers, Inc. /Istanbul Division/ Lehman Brothers, Inc. /Istanbul Division/ Investment ManagersFinance Provides investment banking and securities services	Finance
Caxton Alternative Management LP Caxton Alternative Management LP Investment ManagersFinance CAM Capital seeks to achieve long-term compounded growth of their portfolio using a fundamentally-driven, opportunistic investment strategy. The firm invests in both public and private markets, across the capital structure. CAM Capital’s investments include public and private equity, corporate credit, real estate, and global macro instruments. Their geographic focus is primarily in the Americas and Western Europe.	Finance
Valence Life Sciences LLC Valence Life Sciences LLC Investment ManagersFinance Valence Life Sciences seeks investment opportunities in companies located in the United States. The firm targets companies operating in the fields of private and micro-cap public drug development companies. It provides financing for late stage capital requirements.	Finance
Harvard Business School Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Blackstone Multi-Asset Advisors LLC Blackstone Multi-Asset Advisors LLC Investment ManagersFinance Blackstone Multi-Asset Advisors invests in companies located in the United States. The firm focuses on companies operating across a broad range of sectors and industries. It provides financing for buyout transactions.	Finance
Velicept Therapeutics, Inc. Velicept Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Manufactures biopharmaceutical products	Health Technology
Molecular Templates, Inc. Molecular Templates, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company	Commercial Services
Palvella Therapeutics, Inc. Palvella Therapeutics, Inc. BiotechnologyHealth Technology Engages in developing new therapeutic agents for diseases suffered by patients that lack any treatment choices	Health Technology
Primmune Therapeutics, Inc. Primmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops orally administered toll-like receptor for cancer immunotherapy	Commercial Services
Antios Therapeutics, Inc. Antios Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company focused on development of innovative therapies to treat and cure viral diseases	Commercial Services
Molecular Templates OpCo, Inc. Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Functions as an investment holding company	Finance
Avenge Bio, Inc. Avenge Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as an immuno-oncology company	Health Technology